ARTICLE

FindCenter AddIcon

World-First Clinical Trial Explores Safety and Efficacy of DMT for Major Depression

By Ruairi J. Mackenzie — 2020

The world’s first clinical trial testing the efficacy of the psychedelic compound N,N-dimethyltryptamine (DMT) has won approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Read on www.technologynetworks.com

FindCenter Post-Image

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence

When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...

FindCenter AddIcon
FindCenter Post-Image
20:04

Psychedelics: The Scientific Renaissance of Mind-Altering Drugs

FindCenter AddIcon
FindCenter Post-Image
09:04

Joe Rogan Reacts to Michael Pollan's DMT Story

FindCenter AddIcon
FindCenter Post-Image
01:24:39

Revealing the Mind: The Promise of Psychedelics

Nearly every culture throughout history has used chemicals that alter consciousness for spiritual exploration. In the 20th century these drugs caught the attention of scientists. Psychedelics, as they were named, proved effective at treating intractable illnesses like depression and addiction.

FindCenter AddIcon
FindCenter Post-Image
06:39

Michael Pollan on the Medical Potential of Psychedelics

After decades in the shadows, new studies are looking at psychedelic drugs and their efficacy at treating a variety of psychological issues, including depression.

FindCenter AddIcon
FindCenter Post-Image
01:29:03

Michael Pollan and Tim Ferriss at SXSW 2019

A renaissance is underway in the scientific study of psychedelics, both as a mode of therapy for mental illness and as a tool for understanding the mind.

FindCenter AddIcon
FindCenter Post-Image
52:36

The Science of Psychedelics with Michael Pollan

How could LSD and psilocybin help with mental health, palliative care and addictive behaviours? What was the point of a psilocybin mushroom evolving the way that it did? Michael Pollan explores the “second wave” of international research and discusses what psychedelic drugs may teach us about...

FindCenter AddIcon

EXPLORE TOPIC

DMT